New family of 10 cancer related genes discovered
Introgen Therapeutics, Inc. (NASDAQ: INGN) has licensed a group of newly discovered and sequenced genes that appear to play a critical role in suppressing and preventing the development of lung and other cancers. This family of genes includes at least 10 members. Discovery of these tumor suppressor genes represents a joint collaborative effort by The University of Texas Southwestern Medical Center, The University of Texas M. D. Anderson Cancer Center, and the National Cancer Institute.
C. Channing Burke
Message posted by: Wouter Kalle